2016
DOI: 10.1016/j.ymben.2016.10.017
|View full text |Cite
|
Sign up to set email alerts
|

Engineering a functional 1-deoxy-D-xylulose 5-phosphate (DXP) pathway in Saccharomyces cerevisiae

Abstract: Isoprenoids are used in many commercial applications and much work has gone into engineering microbial hosts for their production. Isoprenoids are produced either from acetyl-CoA via the mevalonate pathway or from pyruvate and glyceraldehyde 3-phosphate via the 1-deoxy-D-xylulose 5-phosphate (DXP) pathway. Saccharomyces cerevisiae exclusively utilizes the mevalonate pathway to synthesize native isoprenoids and in fact the alternative DXP pathway has never been found or successfully reconstructed in the eukaryo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 46 publications
0
39
0
Order By: Relevance
“…It is considered the two biosynthesis steps catalyzed by AsmUdpg and Asm14 may be the limiting steps for the AP‐3 biosynthesis in A. pretiosum . To further deepening the mechanism understanding, more studies such as gene knockout, enzyme activity detection, together with analysis of more intracellular metabolites, and pathway module manipulation are required (Kirby et al, ; Rahman, Hasan, Oba, & Shimizu, ).…”
Section: Discussionmentioning
confidence: 99%
“…It is considered the two biosynthesis steps catalyzed by AsmUdpg and Asm14 may be the limiting steps for the AP‐3 biosynthesis in A. pretiosum . To further deepening the mechanism understanding, more studies such as gene knockout, enzyme activity detection, together with analysis of more intracellular metabolites, and pathway module manipulation are required (Kirby et al, ; Rahman, Hasan, Oba, & Shimizu, ).…”
Section: Discussionmentioning
confidence: 99%
“…The yeast strain was developed where its MVA pathway was replaced with an MEP pathway. The resulting strain showed a slight growth defect made less biomass compared to the wild type, implying slight incompatibility [67].…”
Section: Terpenoidsmentioning
confidence: 98%
“…The yeast strain was developed where its MVA pathway was replaced with an MEP pathway. The resulting strain showed a slight growth defect made less biomass compared to the wild type, implying slight incompatibility [66].…”
Section: Terpenoidsmentioning
confidence: 98%